Literature DB >> 12879575

Efficacy and durability of Bacillus anthracis bacteriophages used against spores.

Michael H Walter1.   

Abstract

Antibiotics and vaccines help fight anthrax disease, but there are no anthrax spore control methods suitable for use in environments where humans are present. The work reported in this article indicates that bacteriophages may help reduce risk from anthrax spores. Dose-response studies demonstrated that higher concentrations of mixed Bacillus anthracis bacteriophages (3.5 x 10(8) plaque-forming units per milliliter) inhibited subsequent growth of bacteria when sprayed on B. anthracis spores. Phages also were tested for durability under conditions designed to simulate environments possibly encountered during mass phage production, storage, and use against anthrax spores. They remained infectious at temperatures from -20 degrees C to 37 degrees C, under filtration, aerosolization, and treatments with perspiration and blood. Phages were sensitive to temperatures over 55 degrees C and to desiccation. Ultraviolet light reduced spore viability more than phage infectivity under similar conditions. The potential for personal or environmental decontamination of anthrax spores with phages is discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12879575

Source DB:  PubMed          Journal:  J Environ Health        ISSN: 0022-0892            Impact factor:   1.179


  5 in total

1.  The mechanism of DNA ejection in the Bacillus anthracis spore-binding phage 8a revealed by cryo-electron tomography.

Authors:  Xiaofeng Fu; Michael H Walter; Angel Paredes; Marc C Morais; Jun Liu
Journal:  Virology       Date:  2011-10-21       Impact factor: 3.616

2.  Expression and purification of recombinant lyase gp17 from the LSB-1 phage in Escherichia coli.

Authors:  Taiwu Wang; Hui Lin; Lu Zhang; Guorong Huang; Long Wu; Lei Yu; Hongyan Xiong
Journal:  Virol Sin       Date:  2015-02       Impact factor: 4.327

3.  Poly-γ-(D)-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophages.

Authors:  David Negus; Jane Burton; Angela Sweed; Romuald Gryko; Peter W Taylor
Journal:  Appl Environ Microbiol       Date:  2012-11-02       Impact factor: 4.792

Review 4.  The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance.

Authors:  Alice Chateau; Sander E Van der Verren; Han Remaut; Antonella Fioravanti
Journal:  Microorganisms       Date:  2020-11-26

Review 5.  Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat.

Authors:  Ewa Jończyk-Matysiak; Marlena Kłak; Beata Weber-Dąbrowska; Jan Borysowski; Andrzej Górski
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.